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Abstract: Reference values are used to describe the dispersion of variables in
healthy individuals. They are usually reported as population-based reference
intervals (RIs) comprising 95% of the healthy population. International rec-
ommendations state the preferred method as a priori nonparametric deter-
mination from at least 120 reference individuals, but acceptable alternative
methods include transference or validation from previously established RIs.
The most critical steps in the determination of reference values are the selec-
tion of reference individuals based on extensively documented inclusion and
exclusion criteria and the use of quality-controlled analytical procedures.
When only small numbers of values are available, RIs can be estimated by
new methods, but reference limits thus obtained may be highly imprecise.
These recommendations are a challenge in veterinary clinical pathology,
especially when only small numbers of reference individuals are available.
Introduction
The concept of reference values was introduced in
1969 by Grasbeck and Saris1 to describe ﬂuctuations
of blood analyte concentrations in well-characterized
groups of individuals. It was intended to replace the
more ambiguous concept of normal values,2,3 and to
‘‘establish a well-deﬁned nomenclature and recom-
mended procedures in the ﬁeld.’’1 In this ﬁrst publica-
tion, there was a clear distinction between healthy
reference values measured in healthy populations or
individuals and patient reference values measured in
patients having various diseases. It is now commonly
accepted that reference values describe ﬂuctuations
observed in healthy populations or individuals, which
makes the deﬁnition of health or characterization of
health status a critical step.
Reference values, ﬁrst introduced as a philosophy,
have gained universal acceptance as one of the most
powerful tools in laboratory medicine to aid in the
clinical decision-making process.3–5 However, the rec-
ommendations for establishing reference intervals (RIs)
described in the original series of articles published by
the International Federation of Clinical Chemistry
(IFCC) and Laboratory Medicine6–11 were sometimes
considered too complicated to be applicable in practice;
and thus, they have been used erroneously, if used at
all. For instance, a recent survey of RIs for serum
creatinine in humans identiﬁed 37 reports of which
only 6 met IFCC criteria.12 These difﬁculties have led
to a necessary revision of the original recommenda-
tions13,14 and the publication of common IFCC and
Clinical Laboratory and Standards Institute (CLSI)
guidelines (C28-A3) in 2008.5 In the latter document,
previous recommendations are reinforced, which
were to establish RIs with at least 120 reference indi-
viduals using the nonparametric ranking method.
However, it is also acknowledged that RI determina-
tion is difﬁcult, time-consuming, and expensive, and
therefore, ‘‘it is unrealistic to expect each laboratory to
develop its own RIs.’’ The new document now allows
individual laboratories to adopt, by transference and
veriﬁcation, RIs established elsewhere. Additionally,
alternate statistical approaches, such as the robust
method, make it possible to establish RIs using smaller
reference sample sizes; however, ‘‘the working group is
hesitant to recommend that it be done (with fewer
than 80 observations), except in the most extreme
instances.’’5
The present review is based on C28-A3 and a
MEDLINE search on the theory and production of ref-
erence values in humans and animals. Only a few of
the numerous articles on this subject (126,242 hits for
‘‘reference values’’ in February 2009) have been se-
lected for this review. General information on refer-
ence values can be found in textbooks,15,16 chapters in
human17 and veterinary18 clinical pathology texts, a
special issue of Clinical Chemistry and Laboratory Medi-
cine,7 and the RefVal computer program of statistical
calculations.19,20
Nomenclature
Standard terms and deﬁnitions
The latest deﬁnitions cited from C28-A35 differ slightly
from the previous IFCC document,6 but the overall
relationships between the terms are the same
(Figure 1).
A reference individual is a person selected for testing
on the basis of well-deﬁned criteria. Reference indi-
viduals are generally assumed to be ‘‘healthy’’; how-
ever, health is relative and lacks a precise and
quantiﬁable deﬁnition. Therefore, reference individu-
als are selected using ‘‘well-deﬁned criteria,’’ ie, inclu-
sion and exclusion criteria, which approximate health.
Inclusion and exclusion criteria should be deﬁned pre-
cisely, according to the aims of the study, and may
differ from one study to another. The RI determined
from the individuals selected according to the given
criteria will be applicable only to similar individuals, ie,
only to individuals fulﬁlling the same criteria.
A reference population is a group consisting of all
possible reference individuals.
A reference sample group is an adequate number of
persons selected to represent the reference population.
Although meant to be representative, the characteris-
tics of a reference sample group are not identical to the
characteristics of the reference population for the fol-
lowing reasons. First, the reference population is hypo-
thetical because the number of individuals it comprises
is unknown. Second, the reference sample group
rarely is selected in a completely random manner.
A reference value is the value, or test result, ob-
tained by the observation or measurement of a partic-
ular type of quantity on a reference individual. A
‘‘particular type of quantity’’21 (‘‘measurand’’ in me-
trology and ‘‘component’’ or ‘‘analyte’’ in laboratory
medicine)22 implies that most of the theory and appli-
cation of reference values deals with univariate RIs,
ie, only 1 analyte at a time, whereas interpretation
of results is mostly multivariate. This has led some
authors to study multivariate reference regions, which
at this time have only limited development.23,24 A ref-
erence value, which represents 1 value obtained in 1
reference individual, is not synonymous with a refer-
ence limit, which is a value derived from all results ob-
tained in the reference sample group. The term
reference value should not be used to denote a limit
of the RI.
A reference distribution is the distribution of refer-
ence values.
Reference limits are the values derived from the ref-
erence distribution and are used for descriptive pur-
poses. Reference limits should not be confused with
decision limits, which are deﬁned below.
An RI is the interval between, and including, 2
reference limits. The RI comprises only a fraction of
the values measured in reference individuals, most
frequently the central 95% of the distribution located
between the 0.025 and 0.975 fractiles as deﬁned by
ISO 15189 and IFCC.10,25 As a consequence, 5% of
healthy individuals have observed values above or be-
low these reference limits. In other words, it is per-
fectly normal to observe abnormal results in healthy
individuals – it just is not frequent. The term ‘‘refer-
ence range,’’ often used as a synonym for RI, is not de-
ﬁned in C28-A3 and therefore should not be used
interchangeably.
An observed value, or patient laboratory test result,
is the value obtained in a test subject that is compared
with reference values, reference distributions, refer-
ence limits, or RIs.
Other potentially confusing terms
Individual RIs are derived from a single individual and
are narrower than population-based RIs.26 Comparing
repeated measurements to the individual RI allows
more efﬁcient interpretation.
Reference change is the difference between 2 succes-
sive values that would be signiﬁcant (P  05) in 95%
of such persons.27 It is based on the ‘‘critical range’’28
(or critical difference) observed in an individual and
encompasses both intra-individual and analytical vari-
ability. A reference change is the most effective ap-
proach by which to detect signiﬁcant changes within
an individual. Because population-based RIs primarily
comprise interindividual variability, they are much too
wide to detect reference changes in an individual.29,30
Because unpredictable and extreme changes can occur
in diseased individuals due to disease progression or
resolution, critical differences, in combination with in-
traindividual reference values, usually are evaluated
only in apparently healthy individuals.26,31
Decision limits (cut-offs, cut-points, or consensus
values32) are thresholds used to classify patients into
diseased vs. non-diseased states or to identify when
medical action is advised, regardless of the reference
limit.33 Decision limits are commonly used in human
medicine for the diagnosis of speciﬁc conditions or risk
factors, eg, fasting plasma glucose concentration for
the diagnosis of diabetes mellitus, or urine pro-
tein:creatinine ratio in dogs and cats.34
A parameter is a quantity that deﬁnes certain char-
acteristics of a population (eg, the mean of a
Figure 1. Relationships between the terms related to reference values according to the Clinical Laboratory and Standards Institute (CLSI) and
International Federation of Clinical Chemistry (IFCC) and Laboratory Medicine document C28-A3.5
population) and does not vary among individuals.
Plasma glucose concentration and alkaline phospha-
tase activity are not parameters, whereas temperature
is a parameter of phosphatase activity measurement.
This word is unduly used in place of ‘‘variable.’’35
A variable is a quantity that varies within or
between individuals and is often confused with pa-
rameter.35 For instance, RBC or plasma cholesterol
concentration are variables.
A conﬁdence interval (CI) contains, within a given
probability, the value of an unknown population pa-
rameter. Because reference limits are determined from
only a sample of the population, they are estimates of
the true limits, which cannot be known; CIs indicate
the imprecision of that estimate. The larger the refer-
ence sample size, the more closely the reference sam-
ple group approximates the reference population and
the narrower the CI.
Prediction interval, a statistical term that has the
same meaning as RI, contains a given percentage of
values of a variable that can be observed in individuals
from a population.
A tolerance interval is an interval within which a
speciﬁed proportion of a population falls with a speci-
ﬁed conﬁdence. It is based on the CIs of limits of a pre-
diction interval. Tolerance interval, RI, and CI of limits
are schematically compared in Figure 2.
Inclusion and exclusion criteria establish whether a
subject is eligible to participate in an RI study. These
criteria are chosen so that only healthy individuals are
included; individuals that are diseased, or do not be-
long to the reference population for whom an RI is be-
ing established, are excluded. Some exclusion criteria,
eg, pregnancy and age, can serve as partitioning crite-
ria. For reference individuals, inclusion and exclusion
criteria can be applied a priori, before the collection of
samples, or a posteriori, after the collection of samples.
Inclusion and exclusion criteria should be determined
before selecting reference individuals or reference
samples from a database. Conformity to selection
criteria may be established by physical examination,
certain measurements or diagnostic tests, and/or com-
pletion of a questionnaire by the person in charge of
the study with the client.5
Reference Values and Health Status
From its inception, and according to IFCC deﬁnition,
reference values are measured in a well-characterized
population of individuals selected according to prede-
ﬁned criteria such as age, sex, breed, nutritional status,
and diet. In addition, it is presumed that reference in-
dividuals are healthy, which raises the question of the
deﬁnition of health. There is no accepted consensus on
the deﬁnition of health. The World Health Organiza-
tion deﬁnition36 is inadequate even for humans and is
not transferable to animals because it is impossible to
deﬁne objective criteria to characterize ‘‘complete
physical, mental, and social well-being.’’ As a conse-
quence, the initial and probably the most problematic
step in the determination of an RI is deﬁning the crite-
ria used to characterize health.37 These criteria must be
clearly described and documented, ‘‘so others can eval-
uate the health status of the reference sample group.’’5
Determination of a Reference Interval
General approaches
There are 3 possible means by which to obtain the RI of
a given analyte for a given population:
(1) determine the RI de novo from measurements
made in reference individuals;
(2) transfer a pre-existing RI when a method/instru-
ment is changed; or
(3) validate a previously established or transferred RI.
De novo determination of RIs is the most fre-
quently used procedure in medical and veterinary
laboratories, as indicated in the original IFCC recom-
mendations. An a priori approach is recommended in
which reference individuals are selected according to
predeﬁned criteria followed by determination of RIs
from the reference values obtained. This approach is
most often performed in a single laboratory, but a mul-
ticentric procedure also is possible if methods and pop-
ulations are comparable. In some cases, an a posteriori
approach is used in which pre-existing data is ex-
ploited to establish reference values. Because inclusion
Figure 2. Schematic representation of a reference interval, reference
limits, conﬁdence intervals (CI) of the limits, and tolerance interval.
and exclusion criteria are applied retrospectively, the
necessary information regarding selection criteria may
not be available.
Stepwise procedures for a priori determination
of a reference interval
The details of the procedure are given in the IFCC-CLSI
C28-A3 guidelines.5 The 13 steps in that document can
be summarized as follows below. All of the steps and
procedures should be fully documented.
Fully document preanalytical, analytical, and biological
factors of variation
The preanalytical, analytical, and biological factors of
variation for each analyte should be determined by a
literature search. Control of clinically meaningful fac-
tors of variation will minimize variability of the results
obtained. Some factors of variability may be used as
exclusion or partitioning criteria (eg, pregnancy). It
may be difﬁcult to control some preanalytical factors of
variation in reference subjects, such as fasting (when
animals are presented for a wellness examination) or
stress in cats. It is difﬁcult to objectively evaluate stress
and to make decisions regarding the degree of stress
that is tolerable in reference subjects. This is especially
true for wild animals in which the level of stress is
quite different, for example, in animals bred in zoos
compared with those caught in the wild.
Establish inclusion and exclusion criteria and
partitioning factors
The objective of the future use of the RI is critical, be-
cause it is the basis for deﬁning the characteristics of
the population to be studied and thus, for choosing in-
clusion, exclusion, and partitioning criteria for the se-
lection of individuals. Minimal criteria of exclusion
include any clinical sign of disease or administration of
medications, perhaps with the exception of ant-
helminthics. Other quantiﬁable exclusion factors that
indicate poor health or undue stress can be added, such
as a body temperature, heart rate, or body condition
score above a certain level. A questionnaire with sim-
ple questions requiring unambiguous answers can aid
in categorizing individuals. An example of such a ques-
tionnaire for humans is given in C28-A35 and can be
adapted to veterinary clinical pathology. Once the
questionnaire is completed by the client and the inves-
tigator, the reference subjects undergo a physical ex-
amination and other testing as necessary or indicated
by the selection protocol. Selected reference individu-
als are then categorized or excluded based on the ex-
clusion criteria or evidence of poor health. The
selection of reference individuals should not be too re-
strictive nor should reference individuals consist only
of healthy young adult animals. All subjective and ob-
jective assessments should be recorded and included in
the reference study document.
Decide on an appropriate number of reference individuals
The appropriate number of reference individuals
should be determined according to the desired CI of
the reference limits. One-hundred and twenty is the
recommended minimum number of individuals in the
reference sample group because it is the smallest num-
ber from which it is possible to estimate the 90% CIs of
the reference limits using the nonparametric meth-
od.10,38 The number of reference values necessary to
achieve a given CI using nonparametric methods is
much higher than by parametric methods, with the
highest numbers required in cases of pronounced
skewness.39–41 In some animal populations (eg, exotic
species) it is extremely difﬁcult to achieve these rec-
ommended reference sample sizes; however, it is still
advised that ‘‘the number of samples should be as high
as possible’’5 without indicating a minimum number.
Prepare the reference individuals and collect and process
the specimens
Preparation of selected reference animals, if necessary,
should be made according to information collected in
the ﬁrst steps (preanalytical, analytical, and biological
factors of variation and inclusion/exclusion criteria).
Specimen type, collection method and specimen han-
dling and processing should be standardized and the
same as for patient specimens. Specimens handled im-
properly or of poor quality (eg, hemolyzed specimens
or samples that have not been stored appropriately)
should be rejected.
Analyze the specimens with a quality-controlled method
Reference specimens should analyzed in the same
manner as for patient specimens. Quality management
of analytical methods is critical for the reliability of the
values obtained.42,43 ‘‘The methods used must be de-
scribed in detail, reporting between-run analytical im-
precision, limit of detection, linearity, recovery, and
interference characteristics, but especially its trueness
and the demonstration of traceability of results pro-
vided to higher order methods or materials, when
they exist.’’5,44,45 Some experts advise that these
speciﬁcations be communicated to clinicians to aid
in the interpretation of results,46 whereas CLSI only
recommends that this information be available upon
request.
Inspect and analyze the data
The reference data should be inspected, the data, a his-
togram prepared, possible errors or outliers identiﬁed,
and the reference limits and their CIs determined. It is
generally agreed that the RI should cover the central
95% of the reference samples collected, limits thus being
the 0.025 and 0.975 fractiles. However, some scientists
suggest that alternative limits be considered, especially
the 0.999 fractile for routine health evaluations, which
would limit the number of false positive results.47
Reference limits should be determined by the non-
parametric method. However, parametric estimation
can be used when data ﬁt or can be transformed to ﬁt a
Gaussian distribution.41,48,49 Transformation is fol-
lowed by a goodness-of-ﬁt test, such as Anderson-
Darling’s.50 Even with transformed data, parametric
estimation of the 0.975 fractile may be biased when
distributions are highly skewed to the right.51 Some
authors recommend comparing RIs obtained by sev-
eral statistical approaches, for example, the nonpara-
metric method, a parametric method with transformed
data, and other methods, such as robust or bootstrap. If
estimates of reference limits are dissimilar, the data set
may be heterogeneous, ie, contain individuals that do
not belong to the underlying population.52,53
There are especially 2 difﬁcult issues that need to
be addressed at this stage: outliers and partitioning.
Outliers are values that do not truly belong to the ref-
erence distribution. Their detection and removal is
critical because ‘‘unless the number of samples is ex-
tremely large, normal range estimation by nonpara-
metric methods almost entirely depends on one or two
lowest and highest values.’’38 However, one has to be
careful to avoid the temptation to eliminate too many
values just to smooth a curve, because the deleted val-
ues may belong to the underlying distribution. ‘‘Unless
outliers are known to be aberrant observations. . .the
emphasis should be on retaining rather than deleting
them.’’5 In addition to visual examination of the histo-
gram, the most frequently used outlier tests are
Dixon–Reed’s and Tukey’s,38 which are relatively
straightforward. Tukey’s method can be performed ac-
curately in the presence of multiple outliers, whereas
the Dixon–Reed test can only be used when 1 outlier is
suspected.5 However, some authors believe even these
methods are insufﬁcient, and that no method opti-
mally detects all outliers.54,55
Partitioning of RIs into subclasses, often based on
sex or age, should be considered if it is clinically useful
or based on physiology.5 However, ‘‘any observed
difference, no matter how small or how questionable
its clinical signiﬁcance, can be statistically signiﬁcant if
the sample sizes are large enough.’’56 The shape of the
distribution57 and/or the prevalence of the subclasses58
also may contribute to signiﬁcant differences between
subclasses even when the means are identical. There is
no consensus on the criteria used to decide whether
partitioning is or is not relevant.59,60 The IFCC-CLSI
C28-A3 guideline recommends use of Harris-Boyd’s z-
test although it is limited to comparisons between 2
subclasses.5,61 An alternative method for the produc-
tion of covariate-dependent RIs (eg, the effect of age) is
the use of regression-based reference limits, which re-
quire very large sample sizes but avoid dividing the val-
ues into subclasses.62,63 These have not been used in
veterinary clinical pathology to our knowledge.
Other options for the determination of a
reference interval
A posteriori determination
When it is too difﬁcult to apply the full a priori proce-
dure, it may be necessary to use values selected from a
databank. However, the same preanalytical, analytical,
and selection factors outlined above should be applied,
and all population and health data should be available
for inspection. The only difference is that the selection
of reference individuals is made after analysis has been
performed.
Indirect determination
As in the a posteriori method, the indirect sampling
technique relies on large databases consisting of both
healthy and diseased individuals, such as hospital re-
cords.64 Indirect methods should not be used except
when no other option is available, due to the likelihood
of erroneous values. Extreme cautionmust be used, and
clinicians should be warned that these RIs are more
likely to contain abnormal values due to generation
from patient databases that contain diseased individuals.
Indirect determination of RIs is based on mathe-
matical methods that separate, as efﬁciently as possi-
ble, healthy from unhealthy individuals. Extracted
data then are used to estimate RIs. This approach is
less reliable when distributions have large skewness
and/or kurtosis.65 Indirect methods probably will have
limited use in veterinary clinical pathology where only
few large databanks are available. To our knowledge,
this has only been used once for serum biochemistry
in sheep,66 and a new method has been proposed
recently.67
Estimation from small sample sizes
Small sample sizes are frequently used to estimate RIs
in veterinary clinical pathology; it is a very problematic
issue. Different methods have been proposed to deal
with small sample groups. The IFCC-CLSI guideline
recommends Horn’s robust method involving iterative
processes for identifying the location of the median
and spread of the distribution.68 In the examples of se-
rum calcium and alanine aminotransferase in men and
women, estimates of RIs by the robust method in sets
of 80 individuals were close to the reference limits and
CIs that were obtained nonparametrically with the full
reference sample group of 120.5 Although some publi-
cations demonstrate robust methods on smaller sample
sizes,65 the IFCC-CLSI working group ‘‘is hesitant to
recommend’’ the robust method with sample sizes of
fewer than 80 individuals.5 In a study of canine plasma
creatinine using multiple small subsets (n=27) ran-
domly selected from 1439 reference samples, it was
shown that the robust method could only be applied
appropriately after transformation of the data to ﬁt a
Gaussian distribution. Depending on the subset se-
lected, the reference limits may be quite different from
those estimated from the entire reference sample
group.69 When reference limits are estimated from
small sample sizes, imprecision of the limits may be
very high. In addition, when nonparametric methods
are used, CIs of the limits are not easily estimated.70
Other methods for estimating RIs in small samples sizes
based on variance component analysis have been used
in human clinical pathology.71
Multicenter reference intervals
The creation of multicenter RIs from the contributions
of multiple laboratories has been successfully estab-
lished and used clinically in human laboratory medi-
cine.72–75 The development of common or shared RIs
was propelled by the necessity to share workload, aug-
ment sample size, and increase the number of analytes
available for diagnostic use. Determination of common
RIs is possible only when there is sufﬁcient compara-
bility of all preanalytical and analytical conditions and
when the reference populations of the different labo-
ratories are similar.76 Common RIs should be validated
or veriﬁed in each laboratory. However, a recent study
in human clinical pathology revealed that adoption of
common RIs should be performed with caution.77,78
Common RIs have yet to be used in veterinary clinical
pathology to our knowledge. However, it may be a
practical option in the future, especially for exotic spe-
cies or groups of animals for which only small sample
sizes can be obtained. Common RIs require large da-
tabases with particular attention to analytical proce-
dures and method accuracy.
Transference of a reference interval
Transference has been used for decades in many labo-
ratories when a new instrument or technique is intro-
duced, but is now accepted by IFCC-CLSI for broader
application.5,79
The following 3 conditions should be fulﬁlled in
order for transference to be acceptable:
1. The RI to be transferred must have been obtained
properly and its generation and other validation
procedures must be fully documented and available
for review. In veterinary clinical pathology labora-
tories, some RI lack complete documentation of the
reference population parameters or analytical spec-
iﬁcations, a situation that should be rectiﬁed in the
future.
2. The analytical systems must be comparable. A clas-
sical procedure for the comparison of methods (see a
review in veterinary clinical pathology80 or CLSI
EP9-A281) is used to determine whether correlation
between the analytical systems is sufﬁciently high to
use regression statistics to calculate a new RI from
the preceding one. Even when correlation is excel-
lent (r24 .9), there may be a signiﬁcant difference
between results of the existing and new systems due
to bias, which may result in differences between the
old and new RIs. For regression methods to be used
properly, test values should have a large enough
range ratio and the intercept should be small rela-
tive to the RI; even then, regression methods may
not be suitable.5,80
3. The patient populations must be comparable. This
implies that complete demographic information on
the original reference sample group is available and
corresponds to the demographics of the new popu-
lation. This is not an issue when a method is
changed within the same laboratory but may be
highly signiﬁcant when RIs are transferred to differ-
ent regions or different countries.
Validation of a reference interval
Validating a pre-existing or a transferred RI avoids the
enormous amount of work and expense necessitated
by a priori determination of an RI. RI validation has
been proposed for more than 15 years82 and, according
to C28-A3, is acceptable by adhering to one of the fol-
lowing 3 procedures.5
Subjective assessment
Acceptability is based on an expert opinion after
careful examination of all conditions by which the
RI was initially determined. These conditions must
be matched by those in the receiving laboratory.
Because this procedure is subjective, it comprises
too many risks to be recommended in veterinary
clinical pathology.
Validation using small numbers of
reference individuals
Acceptability is based on ‘‘examining a small number
of reference individuals (n=20) from the receiving
laboratory’s own population and comparing these
reference values to the larger, more comprehensive
original study.’’ The probability of false rejection of
an RI by this method is o1% when 1 or more sets
of 20 reference individuals is used (binomial test).5
However, this method cannot accurately identify RIs
that are too wide for the new population. A schematic
representation of the procedure is demonstrated in
Figure 3.
Validation using large numbers of
reference individuals
This procedure is roughly analogous to the a priori de-
termination of an RI, except that the number of refer-
ence individuals is o 120. In this case, as stated in the
IFCC-CLSI guidelines, ‘‘the availability of robust statis-
tical techniques provides another alternative.’’5
Conclusions
The general recommendations for the determination
of RIs in medical laboratories are applicable to veteri-
nary clinical pathology. The ﬁrst step in advancing the
science of RI determination in veterinary clinical pa-
thology is to speak the same language, ie, to use the
correct terms according to internationally accepted
deﬁnitions. The second step is to understand the im-
portance of and implement the recommendations for
reference subject selection and quality method perfor-
mance. Collection of as many reference samples as
possible fromwell-deﬁned reference subjects is invalu-
able in the determination of accurate RIs. This will do
more to optimize RIs than the selection of statistical
Figure 3. Algorithm of actions to validate a pre-existing reference interval according to the Clinical Laboratory and Standards Institute (CLSI) and
International Federation of Clinical Chemistry (IFCC) and Laboratory Medicine document C28-A3.5
methods, even though correct selection of the latter
may also improve the accuracy of RIs, especially when
collection of large numbers of specimens is not possi-
ble. Currently, most RIs published in veterinary clini-
cal pathology do not meet the criteria discussed in this
review. The challenge for the future is to make reason-
able and applicable recommendations, especially for
small samples, based on C28-A3, which can be used as
a guideline in veterinary medicine.
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